KAIRE HOLDINGS INC
SB-2, EX-23.2, 2000-12-13
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: KAIRE HOLDINGS INC, SB-2, EX-10.37, 2000-12-13
Next: NORTH AMERICAN DATACOM INC, 10-Q/A, 2000-12-13



<PAGE>

                                                                   Exhibit  23.2


                 CONSENT OF INDEPENDENT CERTIFIED ACCOUNTANTS
                 --------------------------------------------


We have issued our report dated March 17, 2000 accompanying the consolidated
financial statements of KAIRE HOLDINGS INCORPORATED (the "Company") on Form 10-
KSB for the year ended December 31, 1999 which is included in this Registration
Statement.  We consent to the inclusion of our report in the Registration
Statement.


/s/ Berg & Company LLP
----------------------
Berg & Company LLP

San Francisco, California
December 8, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission